Socratec R&D receives accreditation as a research institute recognised by the French government for the corporate tax relief measure that allows French companies to declare innovative research costs and obtain a significant reduction on their tax bill.
The accreditation now achieved for the next years until 2024 gives our French customers the opportunity to use our proven competence and recognised quality in early clinical phases with financial support from the French state and thus to benefit from our comprehensive expertise in design development and realisation of clinical research projects.